• 1. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 2. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 3. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Phenylpiperazines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines Phenylpiperazines

Introduction to 1-2-(2-methoxyethoxy)phenylpiperazine (CAS No. 891782-62-0)

1-2-(2-methoxyethoxy)phenylpiperazine, identified by the Chemical Abstracts Service Number (CAS No.) 891782-62-0, is a compound of significant interest in the field of pharmaceutical chemistry and medicinal research. This molecule, featuring a piperazine core linked to a phenyl group via an ethoxyethoxy bridge, exhibits unique structural and pharmacological properties that make it a valuable candidate for further exploration in drug discovery and development.

The structural motif of 1-2-(2-methoxyethoxy)phenylpiperazine combines the versatility of the piperazine ring, known for its role in various bioactive molecules, with the aromatic system of the phenyl ring. The presence of the 2-methoxyethoxy substituent introduces additional functional diversity, potentially influencing both the solubility and interactions with biological targets. This combination makes the compound a promising scaffold for designing novel therapeutic agents.

In recent years, there has been growing interest in piperazine derivatives due to their broad spectrum of biological activities. Piperazine-based compounds have been investigated for their potential applications in treating neurological disorders, cardiovascular diseases, and infectious diseases. The methoxyethoxy side chain in 1-2-(2-methoxyethoxy)phenylpiperazine adds an extra layer of complexity, which could modulate its pharmacokinetic and pharmacodynamic profiles. This feature is particularly attractive for medicinal chemists seeking to optimize drug-like properties such as bioavailability, metabolic stability, and target specificity.

One of the most compelling aspects of 1-2-(2-methoxyethoxy)phenylpiperazine is its potential as a precursor for more complex derivatives. The piperazine ring can serve as a hinge region, allowing for the attachment of additional pharmacophores that enhance binding affinity or selectivity. Furthermore, the methoxy group on the ethoxyethoxy side chain provides a site for further functionalization, enabling the synthesis of analogs with tailored properties.

Recent studies have highlighted the importance of understanding the three-dimensional structure of bioactive molecules to predict their interactions with biological targets. Computational methods such as molecular docking and molecular dynamics simulations have been increasingly employed to model the binding modes of small molecules like 1-2-(2-methoxyethoxy)phenylpiperazine with protein receptors. These approaches have revealed insights into how structural modifications can influence binding affinity and selectivity, guiding the design of more effective drug candidates.

The synthesis of 1-2-(2-methoxyethoxy)phenylpiperazine involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Key steps typically include nucleophilic substitution reactions to introduce the methoxyethoxy side chain onto the phenyl ring, followed by functionalization of the piperazine nitrogen. Advanced synthetic techniques such as transition-metal-catalyzed cross-coupling reactions have been explored to improve efficiency and scalability.

From a pharmacological perspective, 1-2-(2-methoxyethoxy)phenylpiperazine has shown promise in preclinical studies as a potential therapeutic agent. Its structural features suggest interactions with various neurotransmitter systems, making it a candidate for treating conditions such as depression, anxiety, and cognitive disorders. Additionally, its ability to cross the blood-brain barrier could enhance its therapeutic efficacy in central nervous system disorders.

The development of novel drug candidates is often hampered by challenges such as off-target effects and adverse side effects. However, computational modeling and structure-based drug design strategies have emerged as powerful tools to mitigate these issues. By analyzing the structure-activity relationships (SAR) of 1-2-(2-methoxyethoxy)phenylpiperazine and its derivatives, researchers can identify key structural features that contribute to desired biological activities while minimizing unwanted effects.

The future prospects for 1-2-(2-methoxyethoxy)phenylpiperazine are promising, with ongoing research aimed at expanding its chemical space and exploring new therapeutic applications. Advances in synthetic chemistry and biotechnology continue to provide new opportunities for developing innovative drug candidates based on this scaffold. Collaborative efforts between academic institutions and pharmaceutical companies are essential to translate these findings into clinical applications that benefit patients worldwide.

In conclusion,1-2-(2-meth oxy eth oxy phenyl piperazine (CAS No. 89178 62 0 ) represents a fascinating compound with significant potential in pharmaceutical research . Its unique structural features , combined with promising preclinical results , make it an attractive candidate for further development . As our understanding of molecular interactions continues to evolve , compounds like this will play a crucial role in shaping the future of medicine .

• 13339-01-0(1-(2-Ethoxyphenyl)piperazine)
• 151143-70-3(Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-methyl-)
• 106476-37-3(1-(2-butoxyphenyl)piperazine)
• 148547-51-7(1-(2-methoxyphenyl)-4-methyl-Piperazine)
• 54013-91-1(1-2-(propan-2-yloxy)phenylpiperazine)
• 83081-75-8(1-(2-Ethoxyphenyl)piperazine monohydrochloride 99)
• 35386-24-4(1-(2-Methoxyphenyl)piperazine)
• 111108-39-5(4-(2-ethoxyphenyl)-1-Piperazineethanamine)
• 391926-33-3(Piperazine, 1-[2-[(2S)-oxiranylmethoxy]phenyl]-)
• 1124330-34-2(2-ethoxy-4-(4-methylpiperazin-1-yl)aniline)